Ubisoft's Stock Struggles Amid Mixed Reception of Star Wars Outlaws and Other Titles

Ubisoft is facing a decline in stock market value following the release of Star Wars Outlaws. While many players are just beginning their adventures as mercenaries and rogues in the game, its somewhat tepid reception compared to expectations—especially given it was accompanied by the company's largest marketing effort—has negatively impacted its valuation in the markets.

According to reports from Reuters, Ubisoft’s stock has taken a downturn since August 27, when early access for Star Wars Outlaws became available, coinciding with the day after the game's reviews were published. The company's shares are said to have reached their lowest point since 2015, now priced around €15.2 each. This marks an 85% decline from its peak in July 2018, where shares were valued at €102.95, and a 30% drop since the beginning of the year 2024.

However, attributing this decline solely to Outlaws would be an oversimplification. Ubisoft also launched two other significant titles this year: Skull and Bones and XDefiant, both of which did not meet market expectations. Although XDefiant showed promise initially, interest has waned significantly, leaving doubts about its future. Meanwhile, Skull and Bones remains somewhat under the radar and is currently in its third season, though details on player engagement across PC and consoles are sparse.

Despite the challenges it faces, Ubisoft has a long-standing history and numerous opportunities to win back the trust of its investors. One such example is the recent release of Prince of Persia: The Lost Crown, which showcases quality craftsmanship. Additionally, anticipation builds for Assassin's Creed Shadows, slated for release later this year, which will transport the revered franchise to feudal Japan for the first time.